These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29359982)

  • 21. Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study.
    Ambati SR; Randolph RE; Mennitt K; Kleinert DA; Weinsaft JW; Giardina PJ
    Am J Hematol; 2013 Aug; 88(8):652-6. PubMed ID: 23640778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).
    Ho PJ; Tay L; Teo J; Marlton P; Grigg A; St Pierre T; Brown G; Badcock CA; Traficante R; Gervasio OL; Bowden DK
    Eur J Haematol; 2017 Feb; 98(2):97-105. PubMed ID: 27537786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between vitamin D levels and left ventricular function and NT-proBNP levels among thalassemia major children with iron overload.
    Ambarwati L; Rahayuningsih SE; Setiabudiawan B
    Ann Pediatr Cardiol; 2016; 9(2):126-31. PubMed ID: 27212846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.
    Tantiworawit A; Charoenkwan P; Hantrakool S; Choeyprasert W; Sivasomboon C; Sanguansermsri T
    Int J Hematol; 2016 Jun; 103(6):643-8. PubMed ID: 27052211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moderate to severe liver siderosis and raised AST are independent risk factors for vitamin D insufficiency in β-thalassemia patients.
    Darvishi-Khezri H; Karami H; Naderisorki M; Zahedi M; Razavi A; Kosaryan M; Aliasgharian A
    Sci Rep; 2020 Dec; 10(1):21164. PubMed ID: 33273639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients.
    Ricchi P; Meloni A; Spasiano A; Neri MG; Gamberini MR; Cuccia L; Caruso V; Gerardi C; D'Ascola DG; Rosso R; Campisi S; Rizzo M; Terrazzino F; Vangosa AB; Chiodi E; Missere M; Mangione M; Positano V; Pepe A
    Am J Hematol; 2015 Nov; 90(11):1008-12. PubMed ID: 26228763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting the relationship between vitamin D deficiency, cardiac iron and cardiac function in thalassemia major.
    Noetzli LJ; Carson S; Coates TD; Wood JC
    Eur J Haematol; 2011 Feb; 86(2):176-7. PubMed ID: 20942841
    [No Abstract]   [Full Text] [Related]  

  • 28. [Liver and heart iron deposition status in patients with β thalassemia major: a multicenter study].
    Li C; Liu S; Wang Y; Wen F; Gao H; Chen G; Li C; Wu X; Fang J; Hao W; Liu R; Zhang X; Chu CW; Au W
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):90-3. PubMed ID: 24739717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation Between Cardiac T2* Values and Electrocardiographic Parameters in Children With Transfusion-dependent Thalassemia.
    Aggarwal P; Kumar I; Jain A; Verma A; Gupta V
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e610-e614. PubMed ID: 32032245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia major.
    Dimitriadou M; Christoforidis A; Economou M; Tsatra I; Vlachaki E; Fidani L; Katzos G; Athanassiou-Metaxa M
    Eur J Haematol; 2010 Jan; 84(1):64-71. PubMed ID: 19744128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of Cardiac and Liver Iron Level with T2*MRI and Vitamin D3 Serum Level in Patients with Thalassemia Major.
    Shaykhbaygloo R; Moradabadi A; Taherahmadi H; Rafiei M; Lotfi F; Eghbali A
    J Blood Med; 2020; 11():83-87. PubMed ID: 32210653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload.
    Elalfy MS; Saber MM; Adly AA; Ismail EA; Tarif M; Ibrahim F; Elalfy OM
    Eur J Haematol; 2016 Mar; 96(3):318-26. PubMed ID: 26018112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of heart and liver iron deposition status in patients with β- thalassemia intermedia and major with MRI T2* technique].
    Li CG; Liu SX; Mai HR; Wang Y; Wen FQ; Liu RY; Zhang XH; Chu WC; Au WY
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Feb; 14(2):110-3. PubMed ID: 22357467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).
    Maira D; Cassinerio E; Marcon A; Mancarella M; Fraquelli M; Pedrotti P; Cappellini MD
    Ann Hematol; 2017 Nov; 96(11):1931-1936. PubMed ID: 28875336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration.
    Berdoukas V; Dakin C; Freema A; Fraser I; Aessopos A; Bohane T
    Haematologica; 2005 May; 90(5):685-6. PubMed ID: 15921384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease.
    Wood JC; Tyszka JM; Carson S; Nelson MD; Coates TD
    Blood; 2004 Mar; 103(5):1934-6. PubMed ID: 14630822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D levels and left ventricular function in beta-thalassemia major with iron overload.
    Pala M; Bhat KG; Manya S; Joseph N; Harish S
    Eur J Pediatr; 2023 Apr; 182(4):1749-1754. PubMed ID: 36763189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of iron chelators on myocardial iron and cardiac function in transfusion-dependent thalassaemia: a systematic review and meta-analysis.
    Mamtani M; Kulkarni H
    Br J Haematol; 2008 Jun; 141(6):882-90. PubMed ID: 18355381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias.
    Deborah Chirnomas S; Geukes-Foppen M; Barry K; Braunstein J; Kalish LA; Neufeld EJ; Powell AJ
    Am J Hematol; 2008 Oct; 83(10):781-3. PubMed ID: 18661491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.